| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/11/2013 | WO2013051722A1 Method for producing corneal endothelial cell |
| 04/11/2013 | WO2013051435A1 Therapeutic agent, gene therapy agent, and method for preventing invasion of eosinophil |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130090384 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/11/2013 | US20130090375 Virus-mediated delivery of bevacizumab for therapeutic applications |
| 04/11/2013 | US20130090308 Compositions for the treatment of dry eye |
| 04/11/2013 | US20130089579 Combination of Hyaluronic Acid and Prilocaine |
| 04/11/2013 | CA2851398A1 Compositions for the treatment of dry eye |
| 04/11/2013 | CA2850944A1 Human notch1 decoys |
| 04/11/2013 | CA2792079A1 Combination of hyaluronic acid and prilocaine |
| 04/10/2013 | EP2578574A1 Optically active dibenzylamine derivative, and manufacturing method for same |
| 04/10/2013 | EP2578224A1 Cell growth-promoting peptide and use thereof |
| 04/10/2013 | EP2578219A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 04/10/2013 | EP2576782A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| 04/10/2013 | EP2575881A1 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 04/10/2013 | EP2575854A1 Cyclosporin emulsions |
| 04/10/2013 | EP2575793A1 N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament |
| 04/10/2013 | EP2575792A1 Biguanide compounds and its use for treating cancer |
| 04/10/2013 | CN202859442U Health care eye patch |
| 04/10/2013 | CN103037894A Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 04/10/2013 | CN103037872A Composition for treatment of damaged part |
| 04/10/2013 | CN103037858A Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 04/10/2013 | CN103037857A Compounds for the treatment/prevention of ocular inflammatory diseases |
| 04/10/2013 | CN103031222A Eyesight-improving healthcare wine |
| 04/10/2013 | CN103028097A Traditional Chinese medicine recipe for treating meniere syndrome |
| 04/10/2013 | CN103028061A Traditional Chinese medicine for treating conjunctivitis and preparation method thereof |
| 04/10/2013 | CN103028007A Traditional Chinese medicine decoction for treating chronic conjunctivitis and preparation method thereof |
| 04/10/2013 | CN102204894B Iodized lecithin enteric capsule preparation and preparation method thereof |
| 04/10/2013 | CN102008609B Drug for curing eye dry, pain and itchy diseases |
| 04/10/2013 | CN101732731B Lentiviral vector-mediated gene transfer and uses thereof |
| 04/10/2013 | CN101605784B Aza-bridged-ring compound |
| 04/10/2013 | CN101502553B Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/04/2013 | WO2013047568A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | WO2013047567A1 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient |
| 04/04/2013 | WO2013045694A1 Compositions and methods for the treatment of degenerative retinal conditions |
| 04/04/2013 | WO2013044736A1 Traditional chinese medicine composition for external use in treating xerophthalmia and the preparation method thereof |
| 04/04/2013 | WO2013044362A1 Selected inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044361A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044360A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013005603A9 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 04/04/2013 | WO2013003620A3 Diagnostic methods and apparatus |
| 04/04/2013 | WO2012074856A3 Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
| 04/04/2013 | WO2011068872A8 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 04/04/2013 | US20130085166 Formulations and uses of retinoic acid receptor selective agonists |
| 04/04/2013 | US20130085156 Novel 2-pyridinecarboxamide derivatives |
| 04/04/2013 | CA2850190A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | CA2849816A1 Composition and methods for the treatment of degenerative retinal conditions |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025740A Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
| 04/03/2013 | CN103012248A Synthesis of amino combretastatin derivative and application of amino combretastatin derivative as oral antitumour drug |
| 04/03/2013 | CN103007291A Composition for treating eye diseases by double-target/multi-target small nucleic acid and applications of composition |
| 04/03/2013 | CN103007284A Application of HMGCoA reductase inhibitor in preparation of medicine used for treating xerophthalmia |
| 04/03/2013 | CN103007282A Eye mask based on combination of nitric oxide and Chinese medicinal materials |
| 04/03/2013 | CN103007096A Preparation raw materials of dropping liquid for treating rhinitis and tympanitis and production process thereof |
| 04/03/2013 | CN103007057A Chinese medicament formula for treating Meniere syndrome |
| 04/03/2013 | CN103007035A Liver-clearing and vision-improving boxthorn leaf traditional Chinese medicine tea and preparation method thereof |
| 04/03/2013 | CN103007014A Traditional Chinese medicine composition used for treating xerophthalmia and preparation method thereof |
| 04/03/2013 | CN103006949A Medicinal composition for treating stye |
| 04/03/2013 | CN103006939A Smoking therapy used for treating senile cataract |
| 04/03/2013 | CN103006927A Eye ointment |
| 04/03/2013 | CN103006912A Method for preparing medicine capsule for clearing away heat and loosing bowels and dispelling rheumatism to relieve pain |
| 04/03/2013 | CN103006911A Drug capsule for clearing away heat and loosing bowels and dispelling wind and relieving pain |
| 04/03/2013 | CN103006868A Traditional Chinese medicine composition for treating Behcet diseases |
| 04/03/2013 | CN103006847A Eye drops for treating uveitis and preparation method thereof |
| 04/03/2013 | CN103006828A Medicinal composition for treating conjunctivitis |
| 04/03/2013 | CN103006805A Method for pink eye disease treatment by using traditional Chinese medicine |
| 04/03/2013 | CN103006706A Amniotic membrane liposome for ocular surface reconstruction and preparation method and application thereof |
| 04/03/2013 | CN103006662A Brimonidine and betaxolol composition for local ophthalmology application |
| 04/03/2013 | CN103006605A Bendazac lysine sustained release preparation as well as preparation method and application of preparation |
| 04/03/2013 | CN103005951A Medicine-filled pillow |
| 04/03/2013 | CN102357196B External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof |
| 04/03/2013 | CN102240366B Quality detection method for preparation for vision rehabilitation |
| 04/03/2013 | CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof |
| 04/03/2013 | CN101668533B Use of a masked or coated copper salt for the treatment of macular degeneration |
| 04/03/2013 | CN101514177B Method for extracting lutein from marigold particles |
| 04/03/2013 | CN101396361B Medicine composition containing L-carnosine for suspending the development of the cataract |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators |
| 04/02/2013 | CA2715143C Novel phenylpyrrole derivative |
| 04/02/2013 | CA2565424C Macromolecule-containing sustained release intraocular implants and related methods |
| 04/02/2013 | CA2557531C Artificial physiological salt solution and manufacturing method for same |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2553895C Use of 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, for the preparation of medication useful for the treatment of illnesses linked to pathological choroidal angiogenesis |
| 04/02/2013 | CA2553387C Piperidinyl prostaglandin e analogs |
| 04/02/2013 | CA2533594C Compounds for inflammation and immune-related uses |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 03/28/2013 | WO2013042684A1 Prophylactic and therapeutic agent for neurological diseases using lipoproteins and prophylactic and therapeutic method for neurological diseases |
| 03/28/2013 | WO2013041810A1 Stable, low-toxicity, sterilizable composition for ophthalmic dying |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | US20130079411 Method for preventing or treating a disease, disorder or condition induced by retina ischemia |
| 03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079337 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 03/28/2013 | US20130079317 Methods for treatment of diseases |
| 03/28/2013 | US20130079315 Ophthalmic Gel Compositions |